These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35343944)

  • 1. Highlights in leukemia and lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):1-20. PubMed ID: 35343944
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):1-20. PubMed ID: 35343941
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):1-24. PubMed ID: 35343946
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Winter A
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):14-18. PubMed ID: 35343942
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Goy AH
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):18-23. PubMed ID: 35343947
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):1-20. PubMed ID: 35343935
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Mato A
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):17-19. PubMed ID: 35343936
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Coombs CC
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):1-24. PubMed ID: 35343939
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Chen YB
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):17-23. PubMed ID: 35343940
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 13. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 19. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.